Concepedia

Adnan Alsumali

AA

8

Publications

169

Citations

8

H-Index

2020

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Open Health Systems Laboratory

London School of Hygiene & Tropical Medicine

Adnan Alsumali is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in health policy, public health, and health services research.

ORCID

Top concepts

Publications per year

2020–2024

8

Publications

8

Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US

Hardik Goswami, Adnan Alsumali, Yiling Jiang et al. · PharmacoEconomics · 2022 · 36 citations · Full text

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective

Adnan Alsumali, Laurence Djatche, Andrew Briggs et al. · PharmacoEconomics · 2021 · 31 citations · Full text

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

Adnan Alsumali, Dominik Lautsch, Rongzhe Liu et al. · Advances in Therapy · 2021 · 24 citations · Full text

Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective

Adnan Alsumali, Roy F. Chemaly, Yiling Jiang et al. · Journal of Medical Virology · 2020 · 20 citations

, , +18

Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)

Vallerie V. McLaughlin, Adnan Alsumali, Rongzhe Liu et al. · Advances in Therapy · 2023 · 20 citations · Full text

Rows per page

1–5 of 8